moving from semaglutide to tirzepatide Switching semaglutide: complete transition guide Best Semaglutide / Tirzepatide Miami,

Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M

Overall, both classes are indifferently recommended by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) as first-line therapy in patients with T2DM and established ASCVD or multiple ASCVD risk factors to reduce the risk of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke, and cardiovascular death [6, 7]

It requires a medical evaluation, a BMI of 35 or higher or a BMI of 30-34 with a chronic health condition like heart disease or diabetes,[8] and a mental health screening (some require initial weight loss to prove commitment)

This is why many people on tirzepatide report that their hands, feet, and the tip of their nose feel like ice, even if the rest of their body feels relatively okay

This widespread receptor distribution underlies both the therapeutic benefits and some off-target effects of the class